These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 31838124)

  • 1. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice.
    Paul R; Huysman BC; Maddipati R; Madden T
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S884.e1-S884.e9. PubMed ID: 31838124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with postpartum use of long-acting reversible contraception.
    Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
    Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
    Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
    Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated With Contraceptive Method Choice and Initiation in Adolescents and Young Women.
    Cohen R; Sheeder J; Kane M; Teal SB
    J Adolesc Health; 2017 Oct; 61(4):454-460. PubMed ID: 28712596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of unintended pregnancy and patterns of contraceptive use among racial and ethnic minority women veterans.
    Quinn DA; Sileanu FE; Zhao X; Mor MK; Judge-Golden C; Callegari LS; Borrero S
    Am J Obstet Gynecol; 2020 Oct; 223(4):564.e1-564.e13. PubMed ID: 32142832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.
    Varney SJ; Guest JF
    Pharmacoeconomics; 2004; 22(17):1141-51. PubMed ID: 15612832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of long-acting reversible contraception.
    Winner B; Peipert JF; Zhao Q; Buckel C; Madden T; Allsworth JE; Secura GM
    N Engl J Med; 2012 May; 366(21):1998-2007. PubMed ID: 22621627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Training contraceptive providers to offer intrauterine devices and implants in contraceptive care: a cluster randomized trial.
    Thompson KMJ; Rocca CH; Stern L; Morfesis J; Goodman S; Steinauer J; Harper CC
    Am J Obstet Gynecol; 2018 Jun; 218(6):597.e1-597.e7. PubMed ID: 29577915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants.
    Simmons RG; Sanders JN; Geist C; Gawron L; Myers K; Turok DK
    Am J Obstet Gynecol; 2019 Apr; 220(4):376.e1-376.e12. PubMed ID: 30576664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Acceptability of Certain Contraceptive Methods among Young Women.
    Hoopes AJ; Teal SB; Akers AY; Sheeder J
    J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):274-280. PubMed ID: 29198974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motivational interviewing to promote long-acting reversible contraception among Rwandan couples wishing to prevent or delay pregnancy.
    Mukamuyango J; Ingabire R; Parker R; Nyombayire J; Easter SR; Wall KM; Tichacek A; Nyirazinyoye L; Kaslow N; Allen S; Karita E
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S919.e1-S919.e12. PubMed ID: 31838122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraception after medication abortion in the United States: results from a cluster randomized trial.
    Rocca CH; Goodman S; Grossman D; Cadwallader K; Thompson KMJ; Talmont E; Speidel JJ; Harper CC
    Am J Obstet Gynecol; 2018 Jan; 218(1):107.e1-107.e8. PubMed ID: 28986072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstetrics-gynecology resident long-acting reversible contraception training: the role of resident and program characteristics.
    Maples JM; Espey E; Evans ML; Breeze JL; Ogburn T; Zite NB
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S923.e1-S923.e8. PubMed ID: 31866517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuation and satisfaction of reversible contraception.
    Peipert JF; Zhao Q; Allsworth JE; Petrosky E; Madden T; Eisenberg D; Secura G
    Obstet Gynecol; 2011 May; 117(5):1105-1113. PubMed ID: 21508749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Condom use by Hispanic and African-American adolescent girls who use hormonal contraception.
    Roye CF
    J Adolesc Health; 1998 Oct; 23(4):205-11. PubMed ID: 9763156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible contraceptives: prevalence and inequalities in 23 countries.
    Ponce de Leon RG; Ewerling F; Serruya SJ; Silveira MF; Sanhueza A; Moazzam A; Becerra-Posada F; Coll CVN; Hellwig F; Victora CG; Barros AJD
    Lancet Glob Health; 2019 Feb; 7(2):e227-e235. PubMed ID: 30683240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Funding policies and postabortion long-acting reversible contraception: results from a cluster randomized trial.
    Rocca CH; Thompson KM; Goodman S; Westhoff CL; Harper CC
    Am J Obstet Gynecol; 2016 Jun; 214(6):716.e1-8. PubMed ID: 26692178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.